Fig. 5
From: TET1 mutations as a predictive biomarker for immune checkpoint inhibitors in colon adenocarcinoma
Pathway enrichment analysis of TET1 mutations in COAD patients
Fig. 5 | World Journal of Surgical Oncology
From: TET1 mutations as a predictive biomarker for immune checkpoint inhibitors in colon adenocarcinoma
Pathway enrichment analysis of TET1 mutations in COAD patients